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GABAergic interneurons are local integrators of cortical activity that have been reported
to be involved in the control of cerebral blood flow (CBF) through their ability to produce
vasoactive molecules and their rich innervation of neighboring blood vessels. They form
a highly diverse population among which the serotonin 5-hydroxytryptamine 3A receptor
(5-HT3A)-expressing interneurons share a common developmental origin, in addition to
the responsiveness to serotonergic ascending pathway. We have recently shown that
these neurons regroup two distinct subpopulations within the somatosensory cortex:
Neuropeptide Y (NPY)-expressing interneurons, displaying morphological properties
similar to those of neurogliaform cells and Vasoactive Intestinal Peptide (VIP)-expressing
bipolar/bitufted interneurons. The aim of the present study was to determine the role of
these neuronal populations in the control of vascular tone by monitoring blood vessels
diameter changes, using infrared videomicroscopy in mouse neocortical slices. Bath
applications of 1-(3-Chlorophenyl)biguanide hydrochloride (mCPBG), a 5-HT3R agonist,
induced both constrictions (30%) and dilations (70%) of penetrating arterioles within
supragranular layers. All vasoconstrictions were abolished in the presence of the NPY
receptor antagonist (BIBP 3226), suggesting that they were elicited by NPY release.
Vasodilations persisted in the presence of the VIP receptor antagonist VPAC1 (PG-97-269),
whereas they were blocked in the presence of the neuronal Nitric Oxide (NO) Synthase
(nNOS) inhibitor, L-NNA. Altogether, these results strongly suggest that activation of
neocortical 5-HT3A-expressing interneurons by serotoninergic input could induces NO
mediated vasodilatations and NPY mediated vasoconstrictions.
Keywords: neurovascular coupling, mCPBG, serotonin, U46619, Pet1 knock-out mouse, vasoactive intestinal
peptide, brain slices, neurogliaform cells
INTRODUCTION
Within the cerebral cortex, different types of GABAergic
inhibitory interneurons have been described according to their
distinctive morphological, molecular, and electrophysiological
characteristics (Cauli et al., 1997;Markram et al., 2004; Vitalis and
Rossier, 2011). Although the final classification scheme of corti-
cal interneurons is still a matter of debate (Ascoli et al., 2008),
data from in vitro and in vivo experiments tend to demonstrate
that distinct subpopulations of inhibitory interneurons exert spe-
cific functional roles in the integrative processes of the cortical
network (Whittington and Traub, 2003; Markram et al., 2004;
Fanselow and Connors, 2010; Gentet et al., 2010; Mendez and
Bacci, 2011). Furthermore, some GABAergic interneurons have
been reported recently to be involved in the control of cerebral
blood flow (CBF) through their ability to express and release
vasoactive molecules (Cauli et al., 2004; Cauli and Hamel, 2010).
However, further characterization of these vasoactive interneu-
rons subpopulations remains to be established.
Interestingly, the robust cortical serotoninergic innervation
from raphe nuclei (Reinhard et al., 1979; Steinbusch, 1981; Tork,
1990), which modulate cortical activity (Takeuchi and Sano,
1984; Papadopoulos et al., 1987; DeFelipe et al., 1991) and CBF
(Rapport et al., 1948; Cohen et al., 1996; Riad et al., 1998), pref-
erentially targets inhibitory interneurons (DeFelipe et al., 1991;
Smiley and Goldman-Rakic, 1996; Paspalas and Papadopoulos,
2001). However, the processes by which 5-hydroxytryptamine
(serotonin, 5-HT) acts on the cortical network and CBF are com-
plex and deserve to be further understood. Indeed, responses to
5-HT seem to depend upon the nature of the receptors involved,
and the recruited neuronal populations (Underwood et al., 1992;
Cohen et al., 1996; Foehring et al., 2002).
Serotonin can notably induce a fast excitation of specific
interneuron subpopulations through the activation of the 5-
hydroxytryptamine 3A receptor (5-HT3A) (Ferezou et al., 2002;
Lee et al., 2010) which is the only ionotropic serotonergic recep-
tor (Barnes and Sharp, 1999; Chameau and van Hooft, 2006).
In the mouse primary somatosensory cortex, the 5-HT3A recep-
tor is expressed by two distinct types of interneurons (Vucurovic
et al., 2010). The first one was characterized by a bipolar/bitufted
morphology, an adaptative or bursting firing behavior and the
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frequent expression of the vasoactive intestinal peptide (VIP),
reported to be a vasodilator in the cerebral cortex (McCulloch and
Edvinsson, 1980; Yaksh et al., 1987; Dacey et al., 1988), whereas
the second population of interneurons includes neurogliaform
like regular spiking neurons and therefore frequently expressed
the neuropeptide Y (NPY), a potent vasoconstrictor (Dacey et al.,
1988; Abounader et al., 1995; Cauli et al., 2004). In rat neocorti-
cal slices, it has been shown that electrical stimulation of a single
VIP- or NOS/NPY-expressing interneuron was able to induce a
dilation of nearby microvessels, probably by releasing vasoactive
molecules. Additionally, direct perfusion of VIP or NO donor
onto cortical slices dilated blood vessels, whereas perfusion of
NPY induced vasoconstrictions (Cauli et al., 2004).
In the present study, we investigated how the pharmacological
activation of 5-HT3A-expressing interneurons can induce blood
vessel diameter changes by means of infrared videomicroscopy
on mice cortical slices. We find that activation of 5-HT3A-
expressing interneurons mostly induced vasodilations mediated
by NO release and also, but less frequently, vasoconstrictions
throughNPY release. Our results show that these interneurons are
strategically positioned to transmute incoming neuronal afferent
signals into vascular responses.
MATERIALS ANDMETHODS
ANIMALS AND SURGERY
Animal procedures were conducted in strict compliance with
approved institutional protocols and in accordance with the
provisions for animal care and use described in the European
Communities Council directive of 24 November 1986 (86-16-
09/EEC).
C57Bl6J mice (14–21 days old; Charles River) were used for
vascular reactivity. All animals were housed in a temperature-
controlled (21–25◦C) room under daylight conditions. They
arrived in the laboratory at least 1 week before initiating exper-
iments to acclimate to their new environment.
Immunohistochemistry was performed on a transgenic mouse
line expressing the enhanced green fluorescent protein (GFP)
under the control of the 5-HT3A promoter (5-HT3A:GFP). This
line, obtained by using modified bacterial artificial chromosomes
(BACs) was provided by the GENSAT Consortium (Rockefeller
University-GENSAT Consortium; (Heintz, 2004) andmaintained
under the Swiss genetic background by breeding heterozygous
mice. The selective expression of GFP in 5-HT3 expressing neu-
rons has been previously controlled in the cortex of these mice
(Lee et al., 2010; Vucurovic et al., 2010).
The Pet1 knock-out mouse line (gift from Evan Deneris, Case
Western Reserve University, Cleveland, OH) was maintained on a
C57BL6 genetic background. Heterozygous Pet1+/− females were
mated with Pet1+/− or Pet1−/− males to produce mixed litters.
Genotyping of the progeny was done by PCR analysis of tail DNA
as described previously (Hendricks et al., 2003).
IMMUNOHISTOCHEMISTRY
Neuronal populations expressing 5-HT3A:GFP were analyzed
at postnatal day P18–P25 (n = 6). Animals were deeply anes-
thetized with an intraperitoneal (IP) injection of pentobarbi-
tal (150mg/kg body weight) and perfused transcardially with
4% paraformaldehyde (PFA). Brains were cryoprotected in
30% sucrose and cut on a freezing microtome (35μm). For
immunofluorescence, sections were incubated overnight at 4◦C
with the following antibodies diluted in phosphate buffer (PS)
saline (PBS): chicken anti-GFP (1:1000, Molecular Probes) and
rabbit anti-NPY (1:500, Amersham), rabbit anti-VIP (1:800,
Incstar) or rabbit anti-nNOS (1:400, Santa-Cruz). After wash-
ing in PBS, sections were incubated in alexa 568 conjugated goat
anti-rabbit and alexa 488 conjugated goat anti-chicken antibodies
(1:300; Molecular Probes).
Sections were rinsed in PB, mounted in Vectashield (Vector)
containing 4′,6′-diamidino-2-phenylindole (DAPI) and were
observed with a fluorescent microscope (Leica, DMR). Images
were acquired with a Coolsnap camera (Photometrics).
Quantifications of GFP:5-HT+3A and NOS+, NPY+, or VIP+
cells were performed at the level of the primary somatosensory
cortex, in 500μm-wide cortical strips (data are expressed as
percentages). Three adjacent sections of at least five animals were
used.
The estimation of the neuronal density at specific distances
from the closest penetrating blood vessel was performed on
coronal brain slices (60μm thick) that were fixed by immer-
sion overnight in PFA. Slices were then rinsed in PBS prior
immunolabeling. For immunofluorescence, sections were incu-
bated sequentially overnight at 4◦C with the following antibod-
ies diluted in PBS: rabbit anti-GFP (1:1000, Molecular Probes)
and goat anti-collagen IV (1:400, Millipore). After washing in
PBS, sections were incubated in CY3 conjugated rabbit anti-goat
and alexa 488 conjugated chicken anti-rabbit antibodies (1:300;
Molecular Probes). Sections were rinsed in PB, mounted in
Vectashield (Vector) containing 4′,6′-diamidino-2-phenylindole
(DAPI) and were observed with a fluorescent microscope (Zeiss).
Images were acquired at the level of the somatosensory cor-
tex with a Zeiss microscope equiped with an AxioCam MRm
CDC camera (Zeiss) and three adjacent sections of four animals
were used. When two penetrating blood vessels were identified
the distance of GFP:5-HT+3A cells within the region defined by
these two blood vessels was determined. The distance from the
closest penetrating blood vessel was calculated using Image J
software. The distance from the closest blood vessel and the
center of two adjacent penetrating blood vessels was subse-
quentially subdivided in four equal parts. The percentages of
5-HT3A:GFP+ cells located within these four radial bins were then
calculated.
Some captions were also taken with a Nikon confocal system
and maximal projections were used for illustration.
PREPARATION OF ACUTE CORTICAL SLICES
Mice were rapidly decapitated and brains were quickly removed
and placed into cold (∼4◦C) slicing solution containing
(in mM): 110 choline chloride, 11.6 Na-ascorbate, 7MgCl2,
2.5 KCl, 1.25NaH2PO4, and 0.5 CaCl2, continuously bubbled
with 95% O2–5% CO2. Coronal brain slices (300μm thick)
containing the primary somatosensory cortex were cut with a
vibratome (VT1200S; Leica), and transferred to a holding cham-
ber enclosing artificial cerebrospinal fluid (ACSF) containing
(in mM): 126NaCl, 2.5 KCl, 1.25NaH2PO4, 2 CaCl2, 1MgCl2,
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26NaHCO3, 20 glucose and 1 kynurenic acid (a nonspecific glu-
tamate receptor antagonist, Sigma), constantly oxygenated (95%
O2–5% CO2), kept 30min at 35◦C and then held at room
temperature. Individual slices were next placed in a submerged
recording chamber kept at 32◦C and perfused (1.5ml/min) with
oxygenated ACSF (in the absence of kynurenic acid). Blood ves-
sels were visualized using infrared videomicroscopy with Dodt
gradient contrast optics (Luigs and Neumann) mounted on
an upright microscope (Zeiss) equipped with a CDD camera
(Hamamatsu).
DRUGS
The 5-HT3 receptor selective agonist (1-(3-Chlorophenyl)
biguanide hydrochloride, mCPBG, 100μM, Sigma) was used to
stimulate specifically 5-HT3-expressing interneurons. To block
neuronal synaptic transmission, mCPBG was applied in the pres-
ence and after 10min application of tetrodotoxin (TTX; 1μM;
Latoxan). To block the nNOS, slices were treated for at least
1 h with an irreversible inhibitor of constitutive nitric oxide
synthase (nNOS) and a reversible inhibitor of inducible nitric
oxide synthase (iNOS), Nω-Nitro-L-arginine (L-NNA; 100μM;
Sigma). NPY Y1 receptors were blocked with the selective
antagonist N2-(Diphenylacetyl)-N-[(4-hydroxyphenyl) methyl]-
D-arginine amide (BIBP 3226; 100μM; Sigma). VIP type 1
(VPAC1) receptors of VIP were blocked with the high-affinity,
selective antagonist PG-97-269 (100 nM; Biochem, Shanghai).
The thromboxane A2 receptors agonist (9,11-dideoxy-11a,9a-
epoxymethanoprostaglandin F2α, U46619, 5 nM, Sigma) was
used to pre-constrict the blood vessels.
VASCULAR REACTIVITY
Arterioles remaining in focal plane, exhibiting a well-defined
luminal diameter (10–20μm) and located in the supragranu-
lar layers of the somatosensory cortex were selected for vascular
reactivity. Images of arterioles were acquired every 15 s (Media
Cybernetics). The eventual drift of the images along the time of
the recording was corrected on-line for the z-drift and off-line
for x and y directions using Image Pro Plus 7.0. Manual replace-
ment of the images to minimize the differences between two
consecutive frames was realized by using a subtraction tool from
Image Pro Plus and luminal diameters were quantified at differ-
ent locations along the blood vessel using customwritten routines
running within IgorPro (WaveMetrics) to determine the location
that moved the most.
Control baselines were determined for 5min at the start of
the recording. Unresponsive blood vessels or vessels with unstable
baseline were discarded from the analysis. Vessels were considered
unstable when their diameter moved more than 5% during the
control baseline. Only one vessel per slice was recorded.
As blood vessels in the slice preparation lack intraluminal flow
and pressure (Sagher et al., 1993; Cauli et al., 2004), vasomotor
movements were detected in vessels pre-constricted for 10min
with the thromboxane agonist U46619 (5 nM), which was applied
throughout the experiment. Only blood vessels that presented a
diameter reduction of at least 10% were kept for analyses. The
vasoconstriction of blood vessels induced by U46619 followed an
exponential progression along the time. This exponential drifting
contraction was fitted and subtracted from the recordings using
IgorPro.
Maximal vasomotor responses were then expressed as per-
centages of the mean baseline diameter, which is the averaged
diameter measured during the control period of oneminute, after
correction for the pre-constriction and just before the mCPBG
application.
Themaximal response diameter was averaged between the fifth
and sixth minute after the onset of the mCPBG application for
vasodilations and between the fourth and the fifth minute for
vasoconstrictions.
STATISTICAL ANALYSES
Data were expressed as mean ± standard error of the mean
(SEM). A paired t-test was used to determine the statistical sig-
nificance of vasomotor responses to mCPBG application under
the same conditions and a t-test was used to determine the statis-
tical significance of response amplitudes between different set of
experiments.
RESULTS
DISTRIBUTION OF 5-HT3A-EXPRESSING NEURONS AND
CO-EXPRESSION OF VASOACTIVE MOLECULES IN TRANSGENIC
5-HT3A :GFP MICE
In order to determine the laminar distribution of 5-HT3-
expressing interneurons and the vasoactive molecules that they
express, we used a reporter mouse strain in which the enhanced
GFP expression is under the control of the 5-HT3A promoter
(Heintz, 2001). This 5-HT3A:GFP mouse line provided by
GENSAT shows similar distribution of cortical 5-HT3A:GFP+
neurons, compared to the expression pattern of 5-HT3A tran-
scripts observed in wild type animals (Vucurovic et al., 2010).
The 5-HT3-expressing interneurons are distributed in all cortical
layers (Figure 1), with a higher density in supragranular layers.
We next performed immunohistochemical analyses to assess
the expression of vasoactive molecules in 5-HT3A-expressing
interneurons. Within the primary somatosensory cortex, 5-
HT3A:GFP+ cells frequently co-expressed NPY (31 ± 4.3%),
VIP (30.2 ± 5.2% or nNOS (9.8 ± 0.9%; Figure 2). These
nNOS+/GFP+ cells correspond to 34.4 ± 0.9% of type II nNOS
cells (see Perrenoud et al., 2012), whereas no type I nNOS cell
were found to express 5-HT3.
The proportion of cells in which GFP was co-detected with
one of the three markers is layer dependent (Figure 2D). Indeed,
VIP+/GFP+ interneurons were preferentially located in layers
II-III, while nNOS+/GFP+ and NPY+/GFP+ interneurons were
distributed in all cortical layers. These distributions correspond
to those recently reported by Lee and collaborators for the NPY
and VIP (Lee et al., 2010).
We then determined the relative distribution of 5-HT3A:GFP+
neurons in relation with the closest large penetrating blood vessel
identified on a coronal section at the level of the somatosen-
sory cortex (17–32μm, Figure 3). This was done in layer I and
in layer II were subsequent analyses were performed. In layer I
the distribution of 5-HT3A:GFP+ cells was homogenous between
two penetrating blood vessels (Figure 3A). By contrast, in layer II,
both multipolar 5-HT3A:GFP+ neurons (Figure 3B) and bipolar
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FIGURE 1 | Expression of 5-HT3A within the somatosensory cortex.
(A,B) Coronal section of a 5-HT3A:GFP mouse counterstained with DAPI
showing the preferential location of 5-HT3A-expressing cells in supragranular
layers. (C) Density of 5-HT3A-expressing cells from transgenic 5-HT3A:GFP
mice in the different layers of the primary somatosensory cortex. Scale bar:
250μm.
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FIGURE 2 | Expression of vasoactive molecules in 5-HT3A-expressing
interneurons. (A1–3) Immunodetection of GFP-expressing neurons within the
primary somatosensory cortex of 5-HT3A:GFP+ mice. (B1–3) Immunodetection
of nNOS (B1), NPY (B2) and VIP (B3) within the same areas as in (A). (C1–3)
Overlays showing the colocalization of GFP with nNOS (C1), NPY (C2), or VIP
(C3). (D1–3), Density of 5-HT3A-expressing cells colocalized with nNOS (D1),
NPY (D2), or VIP (D3) in the different layers of the somatosensory cortex.
Examples of co-labeled neurons are pointed by arrows. Scale bar: 65μm.
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5-HT3A:GFP+ neurons (Figure 3C) showed an non-uniform dis-
tributions as the densities of 5-HT3A:GFP+ neurons were higher
closest two the penetrating blood vessel (0–25% away from the
closest blood vessel) then away from it (75–100% for multipo-
lar 5-HT3A:GFP+ neurons, P < 0.05 and 50–100% for bipolar
5-HT3A:GFP+ neurons, P < 0.01).
PHARMACOLOGICAL STIMULATION OF 5-HT3A-EXPRESSING
INTERNEURONS IN CORTICAL SLICES INDUCES VASOMOTOR
MOVEMENTS RECORDED BY INFRARED VIDEOMICROSCOPY
The stimulation of GABAergic interneurons can induce vaso-
motricity via the production of vasoactive substances such as VIP,
NPY, or nitric oxide (NO), a highly diffusible gas which is known
to be a potent vasodilator (Estrada and DeFelipe, 1998; Cauli
et al., 2004; Rancillac et al., 2006). Here we investigated the func-
tional role of 5-HT3-expressing interneurons in the control of
vascular tone within the supragranular layers of the cortex. In this
aim, we applied a 5-HT3R selective agonist mCPBG (100μM)
for 6min, directly onto acute slices while recording associated
blood vessel movements using infrared videomicroscopy. We
focused our study on penetrating arterioles that are known to
be of prime importance in feeding deeply located microvessels
and neurons (Nishimura et al., 2007). Well defined arterioles
of supragranular layers were therefore selected for quantitative
analyses. As blood vessels in the slice preparation lack intra-
luminal flow and pressure (Sagher et al., 1993; Cauli et al.,
2004), vasomotor changes were detected in pre-constricted arte-
rioles using the thromboxane agonist U46619 (5 nM) throughout
the experiment. When bath applied, mCPBG (100μM) induced
FIGURE 3 | 5-HT3A:GFP+ neurons in relation with the closest large
penetrating blood vessel. (A) In layer I, 5-HT3A:GFP+ neurons do
not show specific preferences to be located close to large penetrating
blood vessels. (B,C) By contrast in layer II multipolar and bipolar/bitufted
5-HT3A:GFP+ neurons are preferentially positioned in the vicinity of
penetrating blood vessels. (D) Confocal picture of a coronal section
taken at the level of the supragranular layers of the somatosensory
cortex showing the distribution of 5-HT3A:GFP+ neurons (green) in
relation with blood vessels stained by collagen IV (red). Large penetrating
blood vessel is indicated by a star. (E) Higher power view of the caption
shown in (D). The arrow points to a multipolar 5-HT3A:GFP+ neurons
displaying a large soma. The filled arrowhead points to a bipolar
5-HT3A:GFP+ neurons displaying a fusiform shape. Scale bars: (D) 130μm;
(E) 35μm.
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either reversible vasodilations (111.11 ± 3.03% over baseline,
n = 9/17; P < 0.01; Figures 4A and B) or reversible vasocon-
strictions (90.04 ± 3.15% over baseline, n = 4/17; P < 0.05;
Figures 4C and D).
VASODILATIONS ARE MAINLY MEDIATED BY NOWHEREAS
VASOCONSTRICTIONS ARE DUE TO NPY RELEASE
We hypothesized that mCPBG induced vasodilation could be due
to NO and/or VIP release by 5-HT3AR-interneurons, whereas
vasoconstriction could be caused by NPY release. To deter-
mine the molecular events underlying vasomotor changes, we
successively blocked different possible mechanisms. Lowering
basal NO levels by treatment with the constitutive nNOS inhibitor
L-NNA (100μM) strongly reduced the proportion of vasodila-
tions observed in response to mCPBG applications from 69% in
control conditions to 11% (n = 1/9) and favored vasoconstric-
tions from 31% in control condition to 80% (93.83 ± 1.60 of
baseline diameter; n = 4/9, P < 0.01) (Figures 5A and 6).
FIGURE 4 | mCPBG induces both vasodilations and vasoconstrictions in
somatosensory cortical slices. (A) Mean vascular dilation (n = 9) induced
by mCPBG (100μM). (B) Infrared images of a penetrating blood vessel that
reversibly dilated in response to bath application of mCPBG (100μM). Arrows
indicate region of high vascular reactivity. (C) Mean vascular constriction
(n = 4) induced by mCPBG (100μM). (D) Infrared images of a penetrating
blood vessel that reversibly constricted in response to bath application of
mCPBG (100μM). Scale bar: 10μm.
FIGURE 5 | mCPBG induced vasodilations are mediated by NO
while constrictions are mediated by NPY. (A) Mean vasoconstriction
(n = 4) induced by mCPBG (100μM) in the presence of nNOS inhibitor
L-NNA (100μM) and the preconstricting agent U46619 (5 nM). (B) Mean
vascular dilation (n = 4; white circle) and mean vascular constriction
(n = 2; black diamond) induced by mCPBG (100μM) in the presence
of the VIP receptor VPAC1 antagonist PG-97-269 (100 nM) and U46619
(5 nM). (C) Vasodilation (n = 9) induced by mCPBG (100μM) in the
presence of the NPY Y1 receptor antagonist BIBP 3226 (1μM) and U46619
(5 nM).
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FIGURE 6 | Proportions (A) and amplitudes (B) of dilating or constricting
blood vessels in control condition (CTRL) and in the presence of the
pharmacological blockers used in Figure 5. Note that in presence of the
nNOS inhibitor, L-NNA, as in the presence the Y1 NPY receptor antagonist,
BIBP 3226, the occurrence of dilations versus contractions was reduced or
favored respectively, without impacting their amplitudes. On the opposite, in
the presence of the VPAC1 receptor antagonist of VIP, PG-97-269, no changes
were observed compared to control conditions.
These results suggest that mCPBG-induced vasodilations are
mostly mediated by NO release. The remaining vasodilation
observed in the presence of L-NNA could be mediated by VIP
release. However, in the presence of the VIP receptor VPAC1
antagonist, PG-97-269 (100 nM), mCPBG application induced
60% of vasodilations (110.01 ± 1.87%; n = 3/6; P < 0.05) and
40% of vasoconstrictions (92.04 ± 0.61; n = 2/6; P < 0.05) of
similar proportions and amplitudes compared to control con-
ditions (Figures 5B and 6). Then, to determine the molecular
pathway underlying vasoconstrictions, treatment of mCPBG was
reproduced in the presence of NPY Y1 receptor antagonist (BIBP
3226, 1μM). Indeed, vasoconstrictions mediated by NPY are
known to be mediated by smooth muscle NPY Y1 vascular recep-
tor (Abounader et al., 1999). Under BIBP 3226, constrictions
where blocked and only dilations (108.28 ± 1.62%; n = 9/14;
P < 0.01) could be recorded (Figures 5C and 6). Amplitudes
of vasomotor responses under these different conditions were
not statistically different from control condition (Figure 6B).
Altogether, these data strongly suggest that pharmacological
stimulations of 5-HT3A-expressing interneurons mainly induce
vasodilations through NO release, whereas they induce to a less
extensive vasoconstrictions through NPY release and activation
of its Y1 receptor.
TTX-INSENSITIVE PEPTIDERGIC AND NO RELEASE
It is assumed that peptidergic release requires repetitive action
potentials at high frequencies (Zupanc, 1996; Ludwig and
Pittman, 2003; Baraban and Tallent, 2004) and that nNOS acti-
vation depends on Ca2+ entry (Garthwaite, 2008). Therefore,
we tested mCPBG stimulation in the presence of tetrodotoxin
(TTX, 1μM) to block action potential generation and propaga-
tion. However, this treatment failed to prevent mCPBG-induced
vasodilations (111.45 ± 4.81%; n = 5/10, P < 0.05) or vasocon-
strictions (90.04 ± 2.1%; n = 2/10, P < 0.05), (Figure 7). This
suggests that the vasomotor changes observed in response to
FIGURE 7 | mCPBG induces TTX-insensitive vasodilations and
vasoconstrictions.Mean vascular dilation (n = 5) and constriction (n = 2)
induced by mCPBG (100μM) in the presence of TTX (1μM) and U46619
(5 nM).
5-HT3R activation may depend on the Ca2+ influx through
5-HT3R rather than on action potential generation.
ORIGIN OF 5-HT3R INDUCED NO RELEASE
In the neocortex the 5-HT3AR is exclusively located on
GABAergic interneurons (Morales and Bloom, 1997; Ferezou
et al., 2002; Chameau and van Hooft, 2006; Vucurovic et al.,
2010). However, 5-HT inputs from the raphe also express presy-
naptic 5-HT3ARs regulating neurotransmitter release (Jackson
and Yakel, 1995; Roerig et al., 1997; Nayak et al., 1999). As the
presence of NOS in 5-HT-containing axons from dorsal raphe
has been already reported in the somatosensory cortex (Simpson
et al., 2003) the pharmacological stimulation of 5-HT3Rs realized
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FIGURE 8 | mCPBG induces vasodilations and vasoconstrictions in
Pet1−/− mice. Mean vasodilation (n = 6) and vasoconstriction (n = 3)
induced by mCPBG (100μM) in Pet1−/− mice.
in this study could also have induced NO release from the NOS-
containing fibers originating from raphe nuclei. In order to
evaluate the contribution of such a NO release in our experi-
ments, we used Pet1−/− (Pheochromocytoma 12 ETS factor-1)
knock-out mice, in which raphe projections to the somatosen-
sory cortex were found to be strongly reduced (Hendricks et al.,
1999; Liu et al., 2010). In this mutant mice, we found that phar-
macological stimulation of 5-HT3R could still induce vasodila-
tions (107.07 ± 1.67%; n = 6/11, P < 0.01) or vasoconstrictions
(93.45 ± 2.60%; n = 3/11, P < 0.05), (Figure 8). These vasomo-
tor changes were not significantly different than those induced in
control condition neither in amplitude nor in proportion (from
69 to 67% for vasodilations and from 31 to 33% for vasoconstric-
tions), suggesting a postsynaptic origin of NO release.
DISCUSSION
5-HT3A-expressing interneurons are composed of two different
populations: neurogliaform like interneurons expressing NPY
and bipolar/bitufted interneurons expressing VIP that are likely
candidates to control cortical blood vessels tonus via neuronally
derived vasoactive messengers. In this article we show that in
supragranular layers of the mouse somatosensory cortex, phar-
macological activation of 5-HT3-expressing interneurons can
release of NO to dilate, or NPY to constrict arterioles (Figure 9).
5-HT3AR ACTIVATION INDUCES VASCULAR RESPONSES
THROUGH THE ACTIVATION OF SPECIFIC GABAergic
INTERNEURONS SUBPOPULATIONS
The mechanisms underlying the vasoactive action of serotonin
in the cerebral cortex are not completely understood at present
time. Our results demonstrate that the selective activation of the
ionotropic 5-HT receptor, 5-HT3R, induces a complex vascular
response including both local vasoconstrictions and vasodila-
tions.
These vasomotor changes are not mediated by the presynap-
tic 5-HT3R activation of serotonergic axons originating from
FIGURE 9 | Hypothetical schematic representation of the 5-HT3AR
induction of neurovascular coupling within the somatosensory cortex.
We find that pharmacological stimulation of 5-HT3A-expressing
neurogliaform like cells (in blue) or VIP cells (in green) could either lead to
vasodilation via NO release or vasoconstriction via NPY release. Cortical
penetrating arterioles (in red) are also directly innervated by serotoninergic
fibers originating from raphe nuclei (in purple). Astrocytes are shown in
gray.
raphe nuclei that could potentially release vasoactive substances.
Indeed, they were also observed in Pet-1−/− knock-out mice,
which display a drastic depletion of cortical serotoninergic fibers
(Hendricks et al., 1999; Liu et al., 2010; Kiyasova et al., 2011).
Conversely, our hypothesis is that a specific activation of local
5-HT3A-expressing GABAergic interneurons is responsible for the
observed vasomotor responses.
Indeed, it has been reported that 5-HT3A expression is
confined to GABAergic interneurons in both rat and primate
cerebral cortex (Morales and Bloom, 1997; Jakab and Goldman-
Rakic, 2000; Ferezou et al., 2002). This has been recently con-
firmed in the mouse somatosensory cortex since neither the
pyramidal cell marker Satb2 nor the oligodendrocyte marker
Olig2 could be detected in 5-HT3A-expressing cells (Lee et al.,
2010).
5-HT3A-expressing interneurons constitutes nearly 30% of
the total interneuronal population (Rudy et al., 2011), which
accounts for ∼15% of the overall cortical neurons in rodents
(Beaulieu, 1993; Gabbott et al., 1997). Using an unsupervised
cluster analysis based on 28 electrophysiological parameters, we
have shown in a previous study (Vucurovic et al., 2010) that
5-HT3A-expressing interneurons are segregated into two distinct
subpopulations within the somatosensory cortex. The first one
was characterized by the frequent expression of the NPY (87%)
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and a multipolar morphology, while the second one expressed
frequently the VIP (73%), and presented a bipolar somatoden-
dritic shape. Subsequently, in an article published in 2010, Lee
et al. have suggested, based on immunohistochemical analyses
and electrophysiological recordings, a much broader diversity
of the 5-HT3A-expressing neuronal population. Indeed, ana-
lyzing the intrinsic membrane properties and the morphology
of these neurons, they distinguished seven types of 5-HT3A-
expressing interneurons. Although our separation of these neu-
rons in two subpopulations could therefore appear restrictive;
we consider it is meaningful since it relies on a solid statisti-
cal classification analysis (unsupervised clustering). However, we
do not exclude the existence of some diversity within these two
groups.
In the present study, we analyzed the laminar distribution
of these neuronal populations. We observed that the cell bodies
of more than two-thirds of these interneurons were positioned
within superficial layers (L1, 13 ± 0.9%; L2/3, 51 ± 1.2%) in
agreement with what was recently described (Lee et al., 2010;
Vucurovic et al., 2010). We further revealed that the nNOS is
also expressed by a subset of 5-HT3A-expressing interneurons.
These neurons corresponded to type II NOS+ cells, since they
were smaller than type I and weakly immunohistochemically-
stained for nNOS (Yan et al., 1996; Cho et al., 2010; Perrenoud
et al., 2012). Thus, the distribution and the expression of vasoac-
tive substances within 5-HT3A-expressing interneurons put them
in a unique position to induce a fast and effective modulation of
vascular tone in response to 5-HT.
DUAL ROLE OF 5-HT3A-EXPRESSING INTERNEURONS ON
VASOMOTOR CONTROL
In line with our finding that 5-HT3A-expressing interneurons
produce several vasoactive substances, our results indicate that
their activation induces a complex vascular response. Indeed
the selective 5-HT3R agonist mCPBG induced either constric-
tions (30%) or dilations (70%) of penetrating arterioles within
supragranular layers. All vasoconstrictions were abolished in
the presence of the NPY receptor antagonist (BIBP 3226), sug-
gesting that they were elicited by NPY release. Conversely,
mCPBG-induced dilations were blocked in the presence of a
nNOS inhibitor suggesting that NO is the predominant mes-
senger inducing the vasodilation, in line previous studies per-
formed in the cerebellum (Yang et al., 1999, 2000; Rancillac
et al., 2006) and in the cortex (Estrada and DeFelipe, 1998;
Lovick et al., 1999; Brown et al., 2000; Tong and Hamel, 2000;
Cauli et al., 2004; Liu et al., 2008; Rancillac et al., 2012).
Interestingly, a recent study on epileptic seizures has revealed that
5-HT3 activation can stimulate NO synthesis (Gholipour et al.,
2010).
The NPY-mediated constrictions confirm and extend prior
studies implicating NPY in vasoconstrictions (Dacey et al.,
1988; Abounader et al., 1995; Cauli et al., 2004) and are
likely to be caused by the activation of NPY/5-HT3A-expressing
neurogliaform-like cells (Lee et al., 2010; Vucurovic et al.,
2010).
On the other hand, it has been shown that neurogliaform
cells substantially express nNOS (Karagiannis et al., 2009; Kubota
et al., 2011; Perrenoud et al., 2012) and are thus well positioned to
mediate NO-induced vasodilations. In addition, we have recently
found that a significant proportion of nNOS type II cells express
VIP (Perrenoud et al., 2012). Therefore, a subset of VIP/5-
HT3-expressing cells could also release NO following 5-HT3AR
stimulation (Figure 9).
5-HT3A-nNOS-expressing interneurons could also form a
small third class of 5-HT3A-expressing interneurons that express
neither NPY nor VIP. Although this population has not been iso-
lated with the cluster analysis of these interneurons (Vucurovic
et al., 2010), further triple immunolabeling would be necessary to
assess this possibility.
Unexpectedly, although VIP is present in 5-HT3A-expressing
interneurons, themCPBG-induced dilations persisted in the pres-
ence of the VIP receptor VPAC1 antagonist, suggesting that VIP
release acting on VPAC1 receptors is not involved in this response.
This was surprising since the VPAC1 receptor is a postsynap-
tic receptor predominantly and uniformly expressed by smooth
muscle cells in cerebral arteries and arterioles (Fahrenkrug et al.,
2000) and that direct perfusion of VIP as well as electrical stimu-
lation of a single VIP-expressing interneuron have been reported
to dilate microvessels onto rat slices (Cauli et al., 2004). Moreover,
both light and electron microscopy have revealed that some VIP+
neurons are closely associated with blood vessels, providing a
neuroanatomic substrate for the role of VIP in the regulation of
cerebral blood circulation in the rat cerebral cortex (Eckenstein
and Baughman, 1984; Chédotal et al., 1994a,b; Fahrenkrug et al.,
2000).
In the presence of a nNOS inhibitor, one dilation out of
nine tested blood vessels was still observed (Figure 6A). This
dilation could have been mediated by an activation of perivas-
cular astrocytes resulting from the evoked action potential dis-
charge of 5-HT3 interneurons. Indeed, astrocytes are known
as cellular intermediaries that couple neuronal activity to local
blood flow changes through the phospholipase A2 (PLA2)-
mediated synthesis of arachidonic acid, which leads to production
of prostaglandins and epoxyeicosatrienoic acids (Petzold and
Murthy, 2011). However, Kitaura et al. (2007) have shown that
hindpaw stimulation-induced cortical vasodilations were sup-
pressed inmice lacking nNOS, while they were unchanged inmice
lacking cytosolic phospholipase A2 alpha (cPLA2α).
Together, our observations that in the somatosensory cortex a
selective 5-HT3R agonist induce NOmediated vasodilations con-
firms and extends prior studies reinforcing the central role of NO
in the neurovascular coupling.
TTX-INSENSITIVE VASOMOTOR CHANGES
The cellular mechanisms underlying the release of vasoactive
compounds within the cortex are still poorly considered. Here
we observed that the vascular responses induced by 5-HT3AR
activation were unaffected by the bath application of TTX. This
result indicates that the release of NO, NPY, and VIP by 5-HT3-
expressing interneurons is independent of subthreshold activity,
raising the question of the mode of secretion of these molecules
in the neutrophil.
Studies of hypothalamic neuroendocrine cells indicate that
neuropeptides are confined to large dense-core vesicles and
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released from dendrites and axons (Ludwig and Pittman, 2003)
following high intracellular Ca2+ concentrations (Kits and
Mansvelder, 2000). Action potentials originating at the neu-
ronal soma trigger neuropeptide release from terminals, whereas
Ca2+ release from intracellular stores signals dendritic peptide
release (Ludwig et al., 2002). Similarly, the nNOS enzyme, which
immunoreactivity spreads throughout the cytoplasm of neuronal
cell bodies and their processes (Batista et al., 2001), is well known
to be activated by Ca2+ associated with calmodulin (Bredt et al.,
1991).
Therefore, if these mechanisms are conserved within the cor-
tex, NPY and NO release should also be dependent on high
intracellular Ca2+ concentrations influx. Since 5-HT3ARs are
predominantly expressed at the somatodendritic level in the cor-
tex (Morales et al., 1996; Jakab and Goldman-Rakic, 2000), our
study indicates that the application of mCPBG is likely to evoke
enough intracellular Ca2+ influx through 5-HT3AR to induce
Ca2+ release from intracellular stores and trigger NPY and NO
release.
Several lines of evidence support this hypothesis. In het-
erologous expression systems, the Ca2+ permeability of the
5-HT3R has been reported to be enhanced by co-assembly
of the 5-HT3A subunit with the α-4 subunit of the nicotinic
acetylcholine receptor (van Hooft et al., 1998; Sudweeks et al.,
2002). The existence of functional heteromeric 5-HT3A/nAChα4
receptors has been described in CA1 hippocampal interneurons
(Sudweeks et al., 2002). Lee et al. (2010), recently reported that
in the mouse somatosensory cortex, like in the rat somatosen-
sory cortex (Ferezou et al., 2002), 5-HT3A-expressing neu-
rons respond to both 5-HT3R and nAChR agonists. Hence,
heteromeric 5-HT3/nAChα4 receptors are probably present on
the membrane of cortical 5-HT3A-expressing interneurons and
potentiate the Ca2+ influx evoked by the mCPBG. Altogether,
these results suggests that NPY and NO release were not trig-
gered by action potential generation, but rather by direct Ca2+
entry through homomeric or heteromeric 5-HT3AR channels
in response to mCPBG application, supporting the fact that
TTX blocked neither NO nor neuropeptides induced vasomotor
responses.
IMPACT OF 5-HT3A-EXPRESSING INTERNEURONS ACTIVATION
ON THE CORTICAL NETWORK
In vitro electrophysiological studies have shown that ionotropic
serotonergic receptor agonists induce a fast excitation of
5-HT3A-expressing interneurons through the activation of post-
synaptic somatodendritic receptors (Porter et al., 1999; Zhou
and Hablitz, 1999; Ferezou et al., 2002; Lee et al., 2010). This
activation is likely to have inhibitory impact on the corti-
cal network. Indeed, because supragranular interneurons inner-
vate pyramidal cells, their activation will induce inhibitory
post-synaptic currents in pyramidal neurons and thus inhibits
their firing activity (Zhou and Hablitz, 1999; Moreau et al.,
2010).
Nonetheless, the physiological release of 5-HT by the fibers
originating from the raphe nuclei activate not only 5-HT3ARs, but
also metabotropic serotonin receptors subtypes that are divided
into six classes (5-HT1R, 5-HT2R, and 5-HT4R–5-HT7R) (Hoyer
et al., 1994; Walstab et al., 2010; Pytliak et al., 2011). The con-
sequences of intracerebrally released 5-HT, both on the cortical
network activity and on the CBF will be based on its various
actions through different 5-HTRs (Cohen et al., 1996; Andrade,
2011). Indeed, 5-HT has been reported to have both inhibitory
and excitatory effects on the cortical network (Krnjevic and
Phillis, 1963; Reader, 1978; Waterhouse et al., 1990; Zhou and
Hablitz, 1999; Puig et al., 2005), while it has a negative impact
on the CBF in the neocortex through a major vasoconstrictor role
of 5-HT through 5-HT1B receptors (Cohen et al., 1996; Riad et al.,
1998).
CONCLUSION
Altogether, this study indicates that 5-HT3A-expressing interneu-
rons occupy a strategic position in superficial layers to convey
fast effects of serotonergic modulation, thus modulating cor-
tical network activity and blood supply. The brainstem 5-HT
pathway, in addition to its direct projections and vasomotor
effects on cortical blood vessels, can use 5-HT3A-expressing
interneurons to control and adapt CBF. These results suggest
that blood flow could be enhanced prior to the onset of any
metabolic deficit, reinforcing the “neurogenic” hypothesis of
the neurovascular coupling versus the “metabolic” one (Rossier,
2009).
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